Managing eczema during pregnancy can be challenging, as uncertainty around the safety of available treatments for the mother and fetus can complicate clinical decision-making.
Addressing this concern is the primary objective of a new observational study from MotherToBaby, an organization that provides evidence-based information on medication and other exposures during pregnancy. The organization is currently recruiting pregnant women with moderate to severe atopic dermatitis living in the United States and Canada to evaluate the safety of lebrikizumab (Ebglyss, Lilly).
Lebrikizumab, approved in

Shoulder arthroplasty is the fastest growing joint replacement in the United States.
Heo and colleagues reported total shoulder arthroplasty volume increased 212% between 2012 and 2022, while total hip arthroplasty and knee arthroplasty increased by 45% and 25%, respectively. They also projected that the growth rate of TSA will significantly outpace that of hip and knee arthroplasty by 2035.
Patients who undergo shoulder arthroplasty are younger and often employed with intentions to remain employed. Consider a patient in his late 40s working as a state trooper who presented with severe

Development of alcohol use disorder, depression or stress after a traumatic event was a strong predictor of major adverse cardiac and cerebrovascular events for both men and women, researchers reported.
Evaluation of psychiatric predictors of major adverse events may be an important step in the prediction of CV risk after a traumatic event, according to data published in the Journal of the American Heart Association.
“Experiencing traumatic events can have long-lasting consequences for mental health that can take many forms, but research to date had yet to comprehensively consider these.

Continuous glucose monitoring can be implemented in the ICU, providing glycemic benefits along with cost savings and increased satisfaction among nurses, according to a presenter.
In 2020, U.S. health systems were able to use CGM during inpatient hospitalization of patients with COVID-19 under emergency use authorization from the FDA. In May 2020, healthcare professionals at The Ohio State University (OSU) Wexner Medical Center began using CGM for their patients, according to Eileen R. Faulds, PhD, MS, RN, FNP-BC, assistant professor at the Center for Healthy Aging, Self-Management and Complex

Parkinson’s disease cost Europe 22.8 billion, or about $26.5 billion in direct, informal and indirect costs in 2019, and these costs are expected to grow as PD prevalence increases, according to research published by Movement Disorders.
To find out how these figures compare with cost of care in the United States, we spoke with Zoltan Mari, MD, FAAN, Ruvo Family (Endowed) Chair and director of the Parkinson’s Disease & Movement Disorders Program at the Cleveland Clinic Lou Ruvo Center for Brain Health.
 
Healio: Do you think these findings are surprising or significant? Why or why not?

Weight bias and stigma have been increasingly recognized as a major barrier to effective obesity care and the mental well-being of patients.
Burn more calories, move more to lose more weight. It seems logical. But the evidence has made it increasingly clear that this is a fundamentally incomplete way to think about physical activity.
My perspective regarding this topic shifted over years of practice, and it has shifted even further as I have spent more time in obesity medicine. I now think of physical activity less like a weight loss tool and more like a vital organ — something essential to

Globally, 359 million women are living with chronic kidney disease, with increasing ties to metabolic diseases and CVD, according to study data published in Chinese Medical Journal.
Previous studies have identified the global prevalence of CKD overall. However, the prevalence of CKD and associated risk factors among women is not well understood, according to Lin Sun, MD, PhD, professor in the department of nephrology, Chongbin Liu, MD, both at The Second Xiangya Hospital of Central South University, China, and colleagues.
“Most global epidemiology pools men and women together, so the pattern

Most adults with type 2 diabetes and established atherosclerotic cardiovascular disease are not prescribed an SGLT2 inhibitor or a GLP-1 receptor agonist, according to data published in the American Journal of Preventive Cardiology.
In an analysis of electronic medical records from a single healthcare system, researchers found that 25.3% of adults with type 2 diabetes and atherosclerotic CVD (ASCVD) were prescribed a GLP-1 and 22% were prescribed an SGLT2 inhibitor. Sangeeta R. Kashyap, MD, assistant chief of clinical affairs in the division of endocrinology, diabetes and metabolism at

Medical maximizers have a significantly higher likelihood of accepting and following cancer screening recommendations if told testing will improve their life expectancy.
A survey of nearly 2,500 U.S. adults also showed maximizers, individuals who prefer to receive healthcare services even if benefits may be limited, had significantly lower odds of accepting and following clinician advice to stop screening based on life expectancy.
“Patients have varying preferences for more vs. less care, and that can affect their reactions to care recommendations and decision-making,” Laura E. Brotzman, PhD,

On Sept. 16, 13 organizations recognizing patients with different forms of interstitial lung disease will unite to celebrate the sixth annual ILD Day.
Each year, the topic of the day differs. This year, the focus is on precision medicine in ILD care.
Healthcare professionals, patients and caregivers are invited to a free webinar on ILD Day at 1 p.m. Eastern time to honor the day and learn more about precision medicine.
Ahead of ILD Day, Healio spoke with Amy Hajari Case, MD, chief medical officer of the Pulmonary Fibrosis Foundation (PFF) and member of Healio Pulmonology’s Peer Perspective